Precision Genomics Collaboratory News

Tune Therapeutics, a biotechnology company pioneering the creation of epi-therapeutic medicines, launched today with its powerful and precise genetic tuning platform, TEMPO. This cutting-edge technology dials gene expression up or down to desired levels – with the potential to reverse pathways of cancer, genetic disease, and aging by changing cell fate and function at will.

Lori Orlando, MD, MHS, MMCI, recently spoke with WRAL on the importance of talking with loved ones about family health history. 

Peak achievement in the sciences isn’t measured by stopwatches or goals scored, it goes by citations – the number of times other scientists have referenced your findings in their own academic papers. A high number of citations is an indication that a particular work was influential in moving the field forward.

The National Organization for Rare Disorders (NORD) has designated the Duke Health Rare Disease Center as a NORD Rare Disease Center of Excellence, joining a highly select group of 31 medical centers, nationwide, as part of an innovative network seeking to expand access and advance care and research for rare disease patients in the United States.

A Q&A with Nobel Laureate Jennifer Doudna

The American Society of Human Genetics (ASHG) is a professional organization for researchers and clinicians who specialize in human genetics. They work to advance human genetics and genomics in science, healthy and society through research, education and advocacy. The ASHG Annual Meeting was held October 18-22, and several members of the Precision Genomics Collaboratory presented their research:

Hilmar Lapp is part of an interdisciplinary, multi-institutional collaboration led by Ohio State that will establish a new field of study called “imageomics” that has the potential to transform biomedical, agriculture and basic biological science.

This issue includes:

• Messages from Director Svati Shah and Co-Director Doug Marchuk
• Funding Opportunities from the Collaboratory and around Duke

• News updates from the genomics community

• Featured publications

• Upcoming events, including some big event announcements from the Collaboratory

Read the newsletter

The IGVF Consortium will bring investigators together in a highly collaborative effort to examine how genomes function, how genome function shapes phenotypes, and how these processes are influenced by genomic variation.

The German National Academy of Sciences Leopoldina comprises 1,600 Academy members from over 30 countries, all researchers with outstanding expertise in their respective fields.